Indo Us Bio-Tech

Indo Us Bio-Tech Debt

The Debt of Indo Us Bio-Tech (INDOUS.NS) as of Nov 15, 2026 is 370.36 M INR. In the previous year, Debt was 148.36 M INR — a change of 149.63% (higher).

Debt

370.36 MINR

YoY

149.63%

Last updated:

In 2026, Indo Us Bio-Tech's total debt was 370.36 M INR, a 149.63% change from the 148.36 M INR total debt recorded in the previous year.

The Indo Us Bio-Tech Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2019
54.92 M INR
Jan 1, 2020
78.67 M INR
Jan 1, 2021
114.72 M INR
Jan 1, 2022
37.33 M INR
Jan 1, 2023
17.05 M INR
Jan 1, 2024
28.02 M INR
Jan 1, 2025
148.36 M INR
Jan 1, 2026
370.36 M INR
The Indo Us Bio-Tech Debt history
YEARDebtYoY
370.36 MINR+149.63%
148.36 MINR+429.48%
28.02 MINR+64.37%
17.05 MINR-54.34%
37.33 MINR-67.46%
114.72 MINR+45.84%
78.67 MINR+43.24%
54.92 MINR-12.39%
62.68 MINR+18.82%
52.75 MINR+3.72%
50.86 MINR+205.20%
16.67 MINR+3.51%
16.10 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Indo Us Bio-Tech Stock analysis

What does Indo Us Bio-Tech do? Indo Us Bio-Tech is one of the most popular companies on Eulerpool.

Debt Details

Understanding Indo Us Bio-Tech's Debt Structure

Indo Us Bio-Tech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Indo Us Bio-Tech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Indo Us Bio-Tech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Indo Us Bio-Tech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Indo Us Bio-Tech stock

Debt of Indo Us Bio-Tech is 370.36 M INR in 2026.

Debt of Indo Us Bio-Tech changed from 148.36 M INR to 370.36 M INR, representing a 149.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Indo Us Bio-Tech since 2006 – with annual values, charts, and detailed analysis.

Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Indo Us Bio-Tech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Indo Us Bio-Tech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Indo Us Bio-Tech